Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer

BACKGROUND: The tumorigenesis of prostate cancer involves genetic mutations. Tumour mutational burden (TMB) is an emerging biomarker for predicting the efficacy of immunotherapy. RESULTS: Single-nucleotide polymorphisms were the most common variant type, and C>T transversion was the most commonly...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lijuan, Pan, Shucheng, Zhu, Binbin, Yu, Zhenliang, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905899/
https://www.ncbi.nlm.nih.gov/pubmed/33632199
http://dx.doi.org/10.1186/s12894-021-00795-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905899/
https://www.ncbi.nlm.nih.gov/pubmed/33632199
http://dx.doi.org/10.1186/s12894-021-00795-7

Ejemplares similares